Kind Pharmaceuticals LLC

Quick facts

Phase 3 pipeline

• AND017 · Diabetes
  AND017 is a small molecule that targets the SGLT2 receptor.

Phase 2 pipeline

• AND017 capsules
• AND017 capsules QW · Diabetes
  AND017 capsules QW is a small molecule that targets the SGLT2 receptor.
• AND017 capsules TIW

Phase 1 pipeline

• AND017 multiple dose
• AND017 single dose
• AND019 PO QD

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Kind Pharmaceuticals LLC portfolio CI brief
• Kind Pharmaceuticals LLC pipeline updates RSS